Advancing public health preparedness: Establishment of Nipah virus molecular diagnostic test at the National Reference Laboratory, Sri Lanka

Abstract

Objective: To establish Nipah virus diagnostic capabilities at the National Reference Laboratory in Sri Lanka using the NIV Pune real-time PCR kit.

Methods: Strict safety precautions were adhered during testing due to the high pathogenicity of the Nipah virus, with all diagnostics conducted in a BSL2+ laboratory at the Medical Research Institute in Sri Lanka. RNA extraction was performed using the QIAamp Viral RNA Mini kit. The NIV Pune in-house real-time PCR kit was employed, following established primer/probe sequences and controls. The assay was validated using the Rotor-Gene Q Series Real-time PCR platform.

Results: The validation run of the Nipah virus real-time PCR test demonstrated robust performance, with positive controls consistently detecting Nipah RNA at a Ct value of 21.50±0.01. Negative controls confirmed assay specificity with an external negative control which was also used as an extraction control and showed no interference. The internal control exhibited stable behavior, enhancing confidence in PCR results. The qPCR analysis graph illustrated the successful detection of internal and positive controls, validating the reliability of the assay.

Conclusions: Establishing Nipah virus diagnostic capabilities in Sri Lanka signifies a proactive and collaborative response to the persistent global health threat.

Keywords

Nipah virus / Real-time PCR / Validation / Molecular diagnostics

References

[1] Abeynayake JI, Chathuranga GP, Fernando MAY, Sahoo MK. Surveillance of emerging SARS-CoV-2 variants by nanopore technology-based genome sequencing. Asian Pac J Trop Med 2023; 16(7): 313-320.

[2] Biswas S, Khuntia HK, Bal M, Pati S, Ranjit M. Emerging and re-emerging diseases: A narrative review. One Health Bull 2023; 3(1): 20.

[3] Chua KB, Goh KJ, Wong KT, Kamarulzaman A, Tan PSK, Ksiazek TG, et al. Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. Lancet 1999; 354(9186): 1257-1259.

[4] Palihawadana P. Weekly epidemiological report; Nipah virus infection. [Online]. Available from: https://www.epid.gov.lk/storage/post/pdfs/Vol%2039%20NO%2008%20English.pdf. [Accessed on 28 November 2023].

[5] World Health Organization. Nipah virus outbreaks. 2020. [Online]. Available from: https://www.who.int/news-room/fact-sheets/detail/nipah-virus. [Accessed on 25 November 2023].

[6] Luby SP, Gurley ES, Hossain MJ. Transmission of human infection with Nipah virus. Clin Infect Dis 2009; 49(11): 1743-1748.

[7] Chattu VK, Kumar R, Kumary S, Kajal F, David JK. Nipah virus epidemic in southern India and emphasizing "One Health" approach to ensure global health security. J Family Med Prim Care 2018; 7(2): 275-283.

[8] Garbuglia AR, Lapa D, Pauciullo S, Raoul H, Pannetier D. Nipah virus: An overview of the current status of diagnostics and their role in preparedness in endemic countries. Viruses 2023; 15(10): 2062.

[9] Gurley ES, Montgomery JM, Hossain MJ, Bell M, Azad AK, Islam MR, et al. Person-to-person transmission of Nipah virus in a Bangladeshi community. Emerg Infect Dis 2007; 13(7): 1031-1037.

[10] Guillaume V, Lefeuvre A, Faure C, Marianneau P, Buckland R, Lam SK, et al. Specific detection of Nipah virus using real-time RT-PCR (TaqMan). J Virol Methods 2004; 120(2): 229-237.

[11] Crameri G, Wang LF, Morrissy C, White J, Eaton BT. A rapid immune plaque assay for the detection of Hendra and Nipah viruses and anti-virus antibodies. J Virol Methods 2002; 99(1-2): 41-51.

[12] Drosten C, Gunther S, Preiser W, van der Werf S, Brodt HR, Becker S, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003; 348(20): 1967-1976.

[13] Wong KT, Shieh WJ, Kumar S, Norain K, Abdullah W, Guarner J, et al. Nipah virus pathology working group. Nipah virus infection: Pathology and pathogenesis of an emerging paramyxoviral zoonosis. Am J Pathol 2002; 161(6): 2153-2167.

[14] Mazzola LT, Kelly-Cirino C. Diagnostics for Nipah virus: A zoonotic pathogen endemic to Southeast Asia. BMJ Glob Health 2019. doi:https://doi.org/10.1136/bmjgh-2018-001118.

[15] Garbuglia AR, Lapa D, Pauciullo S, Raoul H, Pannetier D. Nipah virus: An overview of the current status of diagnostics and their role in preparedness in endemic countries. Viruses 2023; 15(10): 2062. doi: https://doi.org/10.3390/v15102062.

[16] Chong HT, Kunjapan SR, Thayaparan T, Tong J, Petharunam V, Jusoh MR, et al. Nipah encephalitis outbreak in Malaysia, clinical features in patients from Seremban. Can J Neurol Sci 2002; 29(1): 83-87.

[17] Bruno L, Nappo MA, Ferrari L, Di Lecce R, Guarnieri C, Cantoni AM, et al. Nipah virus disease: Epidemiological, clinical, diagnostic and legislative aspects of this unpredictable emerging zoonosis. Animals (Basel) 2022; 13(1): 159.

[18] Centers for Disease Control and Prevention (CDC). Nipah virus (NiV). [Online]. Available from: https://www.cdc.gov/vhf/nipah/index.html. [Accessed on 12 June 2023].

[19] Tong S, Chern SW, Li Y, Pallansch MA, Anderson LJ. Sensitive and broadly reactive reverse transcription-PCR assays to detect novel paramyxoviruses. J Clin Microbiol 2008; 46(8): 2652-2658.

[20] Wacharapluesadee S, Lumlertdacha B, Boongird K, Wanghongsa S, Chanhome L, Rollin P, et al. Bat Nipah virus, Thailand. Emerg Infect Dis 2005; 11(12): 1949-1951.

[21] Feldman KS, Foord A, Heine HG, Smith IL, Boyd V, Marsh GA, et al. Design and evaluation of consensus PCR assays for henipaviruses. J Virol Methods 2009; 161(1): 52-57.

[22] Liu J, Ochieng C, Wiersma S, Ströher U, Towner JS, Whitmer S, et al. Development of a TaqMan array card for acute-febrile-illness outbreak investigation and surveillance of emerging pathogens, including Ebola virus. J Clin Microbiol 2016; 54(1): 49-58.

[23] Onyango CO, Loparev V, Lidechi S, Bhullar V, Schmid DS, Radford K, et al. Evaluation of a TaqMan array card for detection of central nervous system infections. J Clin Microbiol 2017; 55(7): 2035-2044.